/Investors

British Patient Capital

Government fund

London · Series A–Growth

Find your way into British Patient Capital

✨ Fox Verdict
Sign up to see your fit
Stage
Series A–Growth
HQ
London, GB
Instruments
Equity
Founded
2018
Tracked investments
16

What they invest in

from 14 of 16 portfolio companies

AI & Machine Learning ×6Biotech ×5Deep Tech ×5Digital Health ×5Healthtech ×5SaaS ×5Medical Devices ×4Enterprise Software ×3

HQs:United Kingdom×7China×1United States×1

Investments · 17 tracked

founders shown can be your intro path

By year:2024 · 22023 · 12022 · 22020 · 12017 · 17 dated

PragmatIC Semiconductorpragmaticsemi.comin𝕏✓ verified

Pragmatic is a European semiconductor company developing clean chips designed to reduce carbon emissions and waste compared to silicon alternatives.

CleantechDeep TechHardwareSemiconductorsCambridge, GB

Scott WhiteinRichard Pricein

Co-investorsCambridge Innovation CapitalIn-Q-TelProsperity7 VenturesARMCatalystNorth East Development Capital Fund+4 more

163163.net

TOM VIP邮箱 provides a paid email service for individuals and businesses, offering SSL-encrypted email, a dedicated VIP channel, and mobile email management integrated with WeChat.

Enterprise SoftwareSaaS

Co-investorsCathay Capital

Accurxaccurx.cominSep 2021

Accurx builds a communication platform that connects patients with healthcare professionals, supporting tasks like appointment booking, patient contact, referrals, video consultations, and health surveys.

Digital HealthHealthtechSaaSLondon, GB

Jacob Haddad(CEO)inLaurence Bargery(Founding CTO)in

Co-investorsEntrepreneur FirstMoonfire VenturesTranspose Platform ManagementAtomicoLakestarLocalGlobe

Alchemab Therapeuticsalchemab.comin𝕏

Alchemab operates a platform that identifies novel drug targets and therapeutics by analyzing patient antibody repertoires using deep B cell sequencing and computational analysis of samples from disease-resilient individuals.

AI & Machine LearningBiotechDeep TechHealthtech

Jane Osbourn(Chief Executive Officer)

Co-investorsSV Health InvestorsDCVC BioRA CapitalDementia Discovery FundLightstone VenturesOno Venture Investment, Inc.+2 more

Cambridge GaN Devicescamgandevices.comin𝕏

Cambridge GaN Devices is a fabless semiconductor company that develops energy-efficient GaN-based power devices for sustainable electronics.

CleantechDeep TechEnergyHardwareSemiconductorsCambridge, GB

Fabio Necco(CEO)in

Co-investorsCambridge Innovation CapitalEMV CapitalIQ CapitalMartlet CapitalParkwalk Advisors

CloudNCcloudnc.comin𝕏Jun 2022

CloudNC develops CAM Assist, software for machine shops that automates programming, quoting, and tool selection to reduce manual work and increase productivity.

Advanced ManufacturingAI & Machine LearningEnterprise SoftwareSaaSLondon, GB

Theo Saville(Founder)inChris Emery(CTO)in

Co-investorsAdelineBackedBootstrap EuropeEntrepreneur FirstEpisode1GRIDS Capital+7 more

ETF Partnersetfpartners.capitalMay 2024

VC fund (founded 2006) supporting entrepreneurs with investment capital and experience.

Co-investorsEnBW New Ventures GmbHKfW CapitalTesi (Finnish Industry Investment Ltd)European Investment Fund

Grey Wolf Therapeuticsgreywolftherapeutics.cominMay 2024 · $50M

Greywolf is a clinical-stage biotech developing antigen modulation therapies, including oral small molecules in Phase 1/2 trials, for people with cancers and autoimmune disorders.

BiotechDigital HealthHealthtechMedical DevicesOxford, GB

Peter Joyce(Co-founder)inTom McCarthy(Co-founder)in

Co-investorsAndera PartnersCanaan PartnersOxford Science EnterprisesPfizer Venture InvestmentsEarlybird Venture CapitalPfizer Ventures

Hoxton Ventureshoxtonventures.comJun 2020

Hoxton Ventures is a venture capital firm that invests in AI and deeptech startups across the UK and Europe, providing capital, compute access, and infrastructure support to founders building transformative companies.

AI & Machine LearningDeep TechSector AgnosticLondon, GB

Hussein Kanji(Founder and Managing Partner)in

Co-investorsAMK Investment OfficeBeast VenturesCisco InvestmentsIsomer CapitalBritish Business BankHoxton Ventures

Nucleomenucleome.comOct 2022

Nucleome develops 3D genomics technology to map genetic variants in the non-coding genome to the genes they dysregulate, with applications in understanding inflammatory diseases and discovering therapeutic targets.

AI & Machine LearningBiotechDeep Tech

Co-investorsM VenturesOxford Science EnterprisesPfizer Venture InvestmentsJJDCPfizer Ventures

Oxxoxx.vc

Oxx is a venture capital firm that invests in European B2B software companies that have reached product-market fit, leading or co-leading rounds of $5–25m to support their scaling.

Enterprise SoftwareSaaS

Mikael Johnsson(Founder)in

Co-investorsKfW CapitalCapital One VenturesOurCrowdOxx

Oxxoysterbay.vc

Oyster Bay is a venture capital firm that invests in impact-driven companies across the food value chain, from agriculture and food-service robotics to alternative ingredients and food brands.

AgTechFoodTechImpact & Social Good

Co-investorsKfW CapitalCapital One VenturesOurCrowdOxx

Perspectumperspectum.comin𝕏Jan 2023

Perspectum develops digital medical technology and diagnostics using multiparametric MRI to assess and diagnose chronic systemic diseases including liver disease, long COVID, diabetes, and cancer for clinicians and patients.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesOxford, GB

Rajarshi Banerjee(CEO)in

Co-investorsBlue Venture FundsHealthQuest CapitalSandbox Industries

Proximieproximie.comin𝕏Jun 2022 · $80M

Proximie provides a cloud-based operating system for connected operating rooms, giving medtech companies and hospitals real-time OR connectivity, structured surgical data, and AI-driven insights.

AI & Machine LearningDigital HealthMedical DevicesSaaSAltrincham

Nadine Haram(Director)inNadine Hachach-Haram(Founder)inJonathan Lim(Director)inScott Huennekens(Director)in

BoardMohammed Shahzad Ahmed Malik(Director)

Co-investorsAdvent Life SciencesCapria VenturesCedar Mundi VenturesCOTU VenturesDraper AssociatesF-Prime Capital+5 more

Purespringpurespringtx.comin𝕏Oct 2024

Purespring develops genetic therapies targeting podocytes to treat renal diseases through its proprietary GlomThera platform.

BiotechDigital HealthHealthtechMedical Devices

Moin Saleem(Co-founder & Chief Scientific Advisor)in

Co-investorsSofinnova PartnersForbionGilde HealthcareAdvent Life Sciences

Quantexaquantexa.comin𝕏Apr 2023

Quantexa is a data, analytics, and AI platform that provides Contextual Decision Intelligence by unifying fragmented data into a connected view and using advanced analytics and explainable AI to uncover hidden patterns and relationships.

AI & Machine LearningData & InfrastructureEnterprise SoftwareLondon, GB

Vishal Marriain

Co-investorsAlbionVCDawn CapitalEvolution Equity PartnersWarburg PincusBNY MellonEvolution Technology+2 more

Portfolio news

latest coverage across their companies
News - Purespring Therapeutics

Purespring · purespringtx.com · Oct 4, 2025

Principals & officers · per Companies House

what is this? ⓘ
Esi Addae Eshun

Secretary · since 2023

Thomas Matthew Horton

Director · British · since 2025

Leandros Kalisperas

Director · British · since 2025

David Louis Taylor

Director · British · since 2022

Ownership & control

Bbb Investment Holdings Limited — 75–100% of shares, 75–100% of voting rights, right to appoint and remove directors

Frequently asked questions

How many investments has British Patient Capital made?
British Patient Capital has 16 tracked investments, including 1 dated in the last 24 months.
What stage does British Patient Capital invest at?
British Patient Capital invests at the Series A, Series B, Series C, Growth stages.
What sectors does British Patient Capital focus on?
British Patient Capital focuses on Sector Agnostic.
Where is British Patient Capital located?
British Patient Capital is headquartered in London, GB.

Similar investors

Featured in lists